PIA
INSM icon

Piedmont Investment Advisors’s Insmed INSM Stock Holding History

Piedmont Investment Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,330
Closed -$31K – 1643
2018
Q2 		$31K Buy
+1,330
New +$34.2K ﹤0.01% 1454

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Piedmont Investment Advisors's INSM Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Insmed (INSM) in Q3 2018, closing a stake of 1,330 shares — an estimated $31K sold.

Piedmont Investment Advisors first reported a position in INSM in Q2 2018 and held it in 1 quarter. The position peaked at $31K in Q2 2018. 123 funds tracked by Wall St. Rank hold INSM as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Insmed position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 1,330 Insmed shares in Q3 2018, an estimated $31K.
  • Piedmont Investment Advisors first reported a position in Insmed in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Insmed position peaked at $31K in Q2 2018.
  • 123 funds tracked by Wall St. Rank held Insmed as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.